Continuous changes in the healthcare reimbursement criteria require executives across the industry to focus on enterprise-wide changes that have a positive effect on supply chain savings. It's a complex problem and it's easy to get distracted on one issue when having the ability to see a clear BIG picture of your entire supply chain is what can lead to the most dramatic results and return on investments.
Register for MHS' webinar on November 01 (2:00pm EST) to learn about how their customers experience an average 4:1 ROI with continual savings into the millions and a positive financial impact to their bottom line through inventory reduction, avoidance of obsolete and expired inventory, improved charge capture for each patient, and physician preference card optimization. Click on http://bit.ly/UvD3nq
Presenters
*Michael Ferris: Co-Founder, MHS with over 30 years of supply chain management experience
*Steve Basiliere: Former Director of Supply Chain Services at Saints Medical Center, Lowell, MA
*Art Kozyrovicius: Finance and Procurement Systems Support at New York-Presbyterian Hospital, New York, NY
WHY ATTEND?
Join a unique discussion with healthcare supply chain thought leaders and understand how to drive significant and sustainable supply chain operational improvements. Get a jump on making an immediate and positive impact on your bottom line as you head into 2013. Register by clicking on http://bit.ly/UvD3nq
Note: Event will be online, through WebEx
Please Register at http://bit.ly/UvD3nq
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).
Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P.
Cancer Causes Control. 2000 Oct;11(9):847-52.
PMID: 11075874
DOI: 10.1023/A:1008923802001
CONCLUSIONS: We conclude that low levels of 25-VD associated with an increased risk for subsequent earlier exposure and more aggressive development of prostate cancer, especially before the andropause.